packageTroriluzole

troriluzole

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Troriluzole was investigated as a treatment for spinocerebellar ataxia. It remains investigational; its European Union marketing application was withdrawn, so it is not an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q56407722 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:troriluzole
ATC codes:N07XX23
DrugBank:DB15079
PubChem CID:121488186
Wikidata:Q56407722
formula:C15H16F3N5O4S
molar mass:419.378 g/mol (PubChem CID 121488186)
logP:1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown